Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:13 PM
Ignite Modification Date:
2025-12-24 @ 2:13 PM
NCT ID:
NCT06120595
Eligibility Criteria:
Inclusion Criteria:
* Participants have had histologically proven M0 breast cancer (stage 0-II) breast cancer that require neoadjuvant or adjuvant chemo- and/or radio-therapy at least and no more than 3 months pre-study initiation.
* Age between 19 and 80 years
* Have increased life expectancy beyond the initial 3 months post-treatment.
* Have the ability to understand protocol, participate in testing and willingness to sign a written informed consent.
* Absence of any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule.
Exclusion Criteria:
* Male breast cancer patients
* Patients that are not willing to sign an informed consent form
* A previous cancer diagnosis (excluding skin cancers treated by surgery only)
* Patients previously treated by any form of chemo/radiotherapy.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
19 Years
Maximum Age:
80 Years
Study:
NCT06120595
Study Brief:
Protocol Section:
NCT06120595